Page 252 - 20211214_OHKF_Health_Finance_Research_Report_E (1)

11. Scenario 2: screening for patients for pre-diabetes and diabetes, with further RAMP
protocol implementation
a. Patients will be screened on an annual basis, unless they have already been
diagnosed with diabetes. If they are diagnosed with diabetes, patients will be placed
in a RAMP programme that is located in the private sector.

b. Costs include:
i. Average yearly cost of standard care for DM management without complications
is HKD 5.9k/person, which includes the cost of running the RAMP
programme. This figure progresses to HKD 9.5k/person in years 2032–2041,
and HKD 15.4k/person in years 2041–2051.
ii. Patients diagnosed with diabetes without complications are provided with an
annual HKD 3,486/person subsidy to purchase additional services to
manage their diagnosis, matching the subsidy provided for GOPC PPP.

iii. Cost of healthcare services to treat a patient with one or more complications is
HKD 123.4k/person/year, which includes the cost of running the RAMP
programme.
iv. The cumulative incidence of complications is 3.81% within a diabetic
population.
c. Patients with diabetes may remit back to having prediabetes at a rate of 7.0%
cumulative incidence.
i. Remission cases will also be distributed homogeneously among individuals with
diabetes, with exception to the first year of diabetes history wherein individuals
will not experience either mortality or remission.

d. Patients will be exposed to different mortality rates at different age demographics.
For the first ten years, the mortality rate is 0.32% and increases to 0.69% for the
years 2032–2041, and 1.59% for years 2042–2051.

250